Skinvisible, Inc. (SKVI)
0.18
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Skinvisible Total Liabilities (Quarterly) : 10.91M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.91M |
| March 31, 2026 | 10.65M |
| December 31, 2025 | 10.39M |
| September 30, 2025 | 10.14M |
| June 30, 2025 | 9.898M |
| March 31, 2025 | 9.629M |
| December 31, 2024 | 9.404M |
| September 30, 2024 | 10.02M |
| June 30, 2024 | 9.745M |
| March 31, 2024 | 9.467M |
| December 31, 2023 | 9.186M |
| September 30, 2023 | 8.904M |
| June 30, 2023 | 8.628M |
| March 31, 2023 | 8.362M |
| December 31, 2022 | 6.887M |
| September 30, 2022 | 6.519M |
| June 30, 2022 | 6.142M |
| March 31, 2022 | 5.814M |
| December 31, 2021 | 5.643M |
| September 30, 2021 | 5.525M |
| June 30, 2021 | 5.336M |
| March 31, 2021 | 5.059M |
| December 31, 2020 | 4.655M |
| September 30, 2020 | 4.344M |
| June 30, 2020 | 3.967M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.612M |
| December 31, 2019 | 3.189M |
| September 30, 2019 | 2.788M |
| June 30, 2019 | 2.442M |
| March 31, 2019 | 5.267M |
| December 31, 2018 | 4.940M |
| September 30, 2018 | 5.303M |
| June 30, 2018 | 7.627M |
| March 31, 2018 | 7.261M |
| December 31, 2017 | 7.392M |
| September 30, 2017 | 7.368M |
| June 30, 2017 | 7.294M |
| March 31, 2017 | 6.883M |
| December 31, 2016 | 6.448M |
| September 30, 2016 | 7.275M |
| June 30, 2016 | 6.886M |
| March 31, 2016 | 6.472M |
| December 31, 2015 | 6.063M |
| September 30, 2015 | 6.105M |
| June 30, 2015 | 5.734M |
| March 31, 2015 | 5.265M |
| December 31, 2014 | 4.997M |
| September 30, 2014 | 4.499M |
| June 30, 2014 | 3.834M |
| March 31, 2014 | 3.765M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Medifast, Inc. | 64.02M |
| Integrated BioPharma, Inc. | 7.687M |
| BioForce Nanosciences Holdings, Inc. | 0.0848M |
| Nevis Brands, Inc. | 0.5354M |
| Skinhealth Systems, Inc. | 431.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1233M |
| Shareholders Equity (Quarterly) | -10.79M |
| Debt to Equity Ratio | -0.5436 |
| Current Ratio | 0.006 |
| Net Debt Paydown Yield | -2.07% |